Of interest, our results showed that tofacitinib reduced the vessel density in arthritis joint of CIA mice and the sera VEGF and Ang-2 levels, confirming our in vitro results about its anti-angiogenic properties. This evidence concerns the gene VEGFA and Arthritis.